- 関
- antifibrinolytic agent、antifibrinolytics、antiplasmin
WordNet
- limit, block, or decrease the action or function of; "inhibit the action of the enzyme"; "inhibit the rate of a chemical reaction"
- control and refrain from showing; of emotions, desires, impulses, or behavior (同)bottle up, suppress
- limit the range or extent of; "Contact between the young was inhibited by strict social customs"
- a substance that retards or stops an activity
- an enzyme that dissolves the fibrin of blood clots (同)fibrinolysin
PrepTutorEJDIC
- 〈感情・欲望・行動・作用など〉‘を'抑制する / (…しないように)〈人〉‘を'抑制する,妨げる《+『名』+『from』+『名』(do『ing』)》
- 抑制する人(物) / 化学反応抑制剤
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/02/18 16:05:11」(JST)
[Wiki en表示]
Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
|
Identifiers |
Symbols |
SERPINF2; A2AP; AAP; ALPHA-2-PI; API; PLI |
External IDs |
OMIM: 613168 MGI: 107173 HomoloGene: 719 GeneCards: SERPINF2 Gene |
Gene Ontology |
Molecular function |
• protease binding
• endopeptidase inhibitor activity
• serine-type endopeptidase inhibitor activity
• protein binding
• protein homodimerization activity
• eukaryotic cell surface binding
|
Cellular component |
• extracellular region
• fibrinogen complex
• extracellular space
• platelet alpha granule lumen
|
Biological process |
• regulation of blood vessel size by renin-angiotensin
• platelet degranulation
• acute-phase response
• blood coagulation
• response to organic substance
• negative regulation of plasminogen activation
• negative regulation of endopeptidase activity
• regulation of proteolysis
• platelet activation
• collagen fibril organization
• positive regulation of collagen biosynthetic process
• fibrinolysis
• positive regulation of cell differentiation
• positive regulation of transcription from RNA polymerase II promoter
• positive regulation of JNK cascade
• blood vessel morphogenesis
• positive regulation of smooth muscle cell proliferation
• positive regulation of stress fiber assembly
• negative regulation of fibrinolysis
• positive regulation of ERK1 and ERK2 cascade
• positive regulation of transforming growth factor beta production
• positive regulation of cell-cell adhesion mediated by cadherin
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
|
Entrez |
5345 |
18816 |
|
Ensembl |
ENSG00000167711 |
ENSMUSG00000038224 |
|
UniProt |
P08697 |
Q61247 |
|
RefSeq (mRNA) |
NM_000934.3 |
NM_008878.2 |
|
RefSeq (protein) |
NP_000925.2 |
NP_032904.1 |
|
Location (UCSC) |
Chr 17:
1.65 – 1.66 Mb |
Chr 11:
75.43 – 75.44 Mb |
|
PubMed search |
[1] |
[2] |
|
|
Alpha 2-antiplasmin (or α2-antiplasmin or plasmin inhibitor) is a serine protease inhibitor (serpin) responsible for inactivating plasmin, an important enzyme that participates in fibrinolysis and degradation of various other proteins. This protein is encoded by the SERPINF2 gene.[1]
Fibrinolysis (simplified). Blue arrows denote stimulation, and red arrows inhibition.
Contents
- 1 Role in disease
- 2 Interactions
- 3 See also
- 4 References
- 5 Further reading
- 6 External links
|
Role in disease
Very few cases (<20) of A2AP deficiency have been described. As plasmin degrades blood clots, impaired inhibition of plasmin leads to a bleeding tendency, which was severe in the cases reported.
In liver cirrhosis, there is decreased production of alpha 2-antiplasmin, leading to decreased inactivation of plasmin and an increase in fibrinolysis. This is associated with an increase risk of bleeding in liver disease. [2]
Interactions
Alpha 2-antiplasmin has been shown to interact with Plasmin[3][4] and Neutrophil elastase.[4][5]
See also
References
- ^ "Entrez Gene: SERPINF2 serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5345.
- ^ Sattar, Husain. Fundamentals of Pathology. Pathoma LLC, 2011, p. 36.
- ^ Wiman, B; Collen D (September 1979). "On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin". J. Biol. Chem. (UNITED STATES) 254 (18): 9291–7. ISSN 0021-9258. PMID 158022.
- ^ a b Shieh, B H; Travis J (May. 1987). "The reactive site of human alpha 2-antiplasmin". J. Biol. Chem. (UNITED STATES) 262 (13): 6055–9. ISSN 0021-9258. PMID 2437112.
- ^ Brower, M S; Harpel P C (August 1982). "Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase". J. Biol. Chem. (UNITED STATES) 257 (16): 9849–54. ISSN 0021-9258. PMID 6980881.
Further reading
- Martí-Fàbregas J, Borrell M, Cocho D et al. (2008). "Change in hemostatic markers after recombinant tissue-type plasminogen activator is not associated with the chance of recanalization". Stroke 39 (1): 234–6. doi:10.1161/STROKEAHA.107.493767. PMID 18048863.
- Nielsen VG (2007). "Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions". Blood Coagul. Fibrinolysis 18 (7): 647–56. doi:10.1097/MBC.0b013e3282a167dc. PMID 17890952.
- Sazonova IY, Thomas BM, Gladysheva IP et al. (2007). "Fibrinolysis is amplified by converting alpha-antiplasmin from a plasmin inhibitor to a substrate". J. Thromb. Haemost. 5 (10): 2087–94. doi:10.1111/j.1538-7836.2007.02652.x. PMID 17883703.
- Mutch NJ, Thomas L, Moore NR et al. (2007). "TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots". J. Thromb. Haemost. 5 (4): 812–7. doi:10.1111/j.1538-7836.2007.02430.x. PMID 17388801.
- Christiansen VJ, Jackson KW, Lee KN, McKee PA (2007). "The effect of a single nucleotide polymorphism on human α2-antiplasmin activity". Blood 109 (12): 5286–92. doi:10.1182/blood-2007-01-065185. PMC 1890835. PMID 17317851. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1890835/.
- Hayashido Y, Hamana T, Ishida Y et al. (2007). "Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion". Oncol. Rep. 17 (2): 417–23. PMID 17203182.
- Shibata N, Kawarai T, Meng Y et al. (2007). "Association studies between the plasmin genes and late-onset Alzhemier's disease". Neurobiol. Aging 28 (7): 1041–3. doi:10.1016/j.neurobiolaging.2006.05.028. PMC 2647723. PMID 16828203. //www.ncbi.nlm.nih.gov/pmc/articles/PMC2647723/.
- Liu T, Qian WJ, Gritsenko MA et al. (2006). "Human Plasma N-Glycoproteome Analysis by Immunoaffinity Subtraction, Hydrazide Chemistry, and Mass Spectrometry". J. Proteome Res. 4 (6): 2070–80. doi:10.1021/pr0502065. PMC 1850943. PMID 16335952. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1850943/.
- Lee KN, Jackson KW, Christiansen VJ et al. (2004). "A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion". Blood 103 (10): 3783–8. doi:10.1182/blood-2003-12-4240. PMID 14751930.
- Anderson NL, Polanski M, Pieper R et al. (2004). "The human plasma proteome: a nonredundant list developed by combination of four separate sources". Mol. Cell Proteomics 3 (4): 311–26. doi:10.1074/mcp.M300127-MCP200. PMID 14718574.
- Kapadia C, Yousef GM, Mellati AA et al. (2004). "Complex formation between human kallikrein 13 and serum protease inhibitors". Clin. Chim. Acta 339 (1–2): 157–67. doi:10.1016/j.cccn.2003.10.009. PMID 14687906.
- Matsuno H, Okada K, Ueshima S et al. (2004). "Alpha2-antiplasmin plays a significant role in acute pulmonary embolism". J. Thromb. Haemost. 1 (8): 1734–9. doi:10.1046/j.1538-7836.2003.00252.x. PMID 12911586.
- Magklara A, Mellati AA, Wasney GA et al. (2003). "Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors". Biochem. Biophys. Res. Commun. 307 (4): 948–55. doi:10.1016/S0006-291X(03)01271-3. PMID 12878203.
- Cardoso C, Leventer RJ, Ward HL et al. (2003). "Refinement of a 400-kb Critical Region Allows Genotypic Differentiation between Isolated Lissencephaly, Miller-Dieker Syndrome, and Other Phenotypes Secondary to Deletions of 17p13.3". Am. J. Hum. Genet. 72 (4): 918–30. doi:10.1086/374320. PMC 1180354. PMID 12621583. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1180354/.
- Frank PS, Douglas JT, Locher M et al. (2003). "Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide". Biochemistry 42 (4): 1078–85. doi:10.1021/bi026917n. PMID 12549929.
- Strausberg RL, Feingold EA, Grouse LH et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932. //www.ncbi.nlm.nih.gov/pmc/articles/PMC139241/.
- Turner RB, Liu L, Sazonova IY, Reed GL (2002). "Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin". J. Biol. Chem. 277 (36): 33068–74. doi:10.1074/jbc.M203782200. PMID 12080056.
- Askew YS, Pak SC, Luke CJ et al. (2002). "SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinases". J. Biol. Chem. 276 (52): 49320–30. doi:10.1074/jbc.M108879200. PMID 11604408.
- Uszynski M, Klyszejko A, Zekanowska E (2001). "Plasminogen, alpha(2)-antiplasmin and complexes of plasmin-alpha(2)-antiplasmin (PAP) in amniotic fluid and blood plasma of parturient women". Eur. J. Obstet. Gynecol. Reprod. Biol. 93 (2): 167–71. doi:10.1016/S0301-2115(00)00283-9. PMID 11074138.
- Hevessy Z, Patthy A, Kárpáti L, Muszbek L (2000). "alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study". Thromb. Res. 99 (4): 399–406. doi:10.1016/S0049-3848(00)00261-9. PMID 10963790.
External links
- The MEROPS online database for peptidases and their inhibitors: I04.023
- alpha-2+Antiplasmin at the US National Library of Medicine Medical Subject Headings (MeSH)
- SERPINF2+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)
Proteins: coagulation
|
|
Coagulation factors |
Primary hemostasis
|
- platelet membrane glycoproteins: Ib (A
- B
- IX)
- IIb/IIIa (IIb
- IIIa)
- VI
|
|
Intrinsic pathway
|
- HMWK/Bradykinin
- Prekallikrein/Kallikrein
- XII "Hageman"
|
|
Extrinsic pathway
|
|
|
Common pathway
|
- X
- V
- II "(Pro)thrombin"
- I "Fibrin"
- Fibrinogen (FGA, FGG)
|
|
|
Coagulation inhibitors |
- Antithrombin (inhibits II, IX, X, XI, XII)
- Protein C (inhibits V, VIII)/Protein S (cofactor for protein C)
- Protein Z (inhibits X)
- ZPI (inhibits X, XI)
- TFPI (inhibits III)
|
|
Thrombolysis/fibrinolysis |
- Plasmin
- tPA/urokinase
- PAI-1/2
- α2-AP
- α2-macroglobulin
- TAFI
|
|
|
cell/phys (coag, heme, immu, gran), csfs
|
rbmg/mogr/tumr/hist, sysi/epon, btst
|
drug (B1/2/3+5+6), btst, trns
|
|
|
|
Serpins
|
|
inhibitory |
- Alpha 1-antichymotrypsin
- Alpha 1-antitrypsin
- Alpha 2-antiplasmin
- Antithrombin
- C1-inhibitor
- Heparin cofactor II
- Protein C inhibitor
- Plasminogen activator inhibitor-1
- Plasminogen activator inhibitor-2
- Protein Z-related protease inhibitor
- SERPINA1
- SERPINA2
- SERPINA3
- SERPINA4
- SERPINA5
- SERPINA6
- SERPINA7
- SERPINA8
- SERPINA9
- SERPINA14
- SERPINB1
- SERPINB2
- SERPINB3
- SERPINB4
- SERPINB5
- SERPINB6
- SERPINB7
- SERPINB8
- SERPINB9
- SERPINB13
- SERPINC1
- SERPIND1
- SERPINE1
- SERPINE2
- SERPINE2
- SERPINF1
- SERPING1
- SERPINH1
- SERPINI1
- SERPINI2
|
|
Cross class inhibitory |
|
|
noninhibitory |
- Heat shock protein 47
- Maspin
- Ovalbumin
- SERPINF1
- Thyroxine-binding globulin
- Transcortin
- SERPINF1
|
|
see also disorders of globin and globulin proteins
|
|
Proteins: Globular proteins
|
|
Serum globulins |
Alpha globulins
|
serpins: alpha-1 (Alpha 1-antichymotrypsin, Alpha 1-antitrypsin) · alpha-2 (Alpha 2-antiplasmin) · Antithrombin (Heparin cofactor II)
carrier proteins: alpha-1 (Transcortin) · alpha-2 (Ceruloplasmin) · Retinol binding protein
other: alpha-1 (Orosomucoid) · alpha-2 (alpha-2-Macroglobulin, Haptoglobin)
|
|
Beta globulins
|
carrier proteins: Sex hormone-binding globulin · Transferrin
other: Angiostatin · Hemopexin · Beta-2 microglobulin · Factor H · Plasminogen · Properdin
|
|
Gamma globulin
|
Immunoglobulins
|
|
Other
|
Fibronectin (Fetal fibronectin) · Macroglobulin/Microglobulin · Transcobalamin
|
|
|
Other globulins |
Beta-lactoglobulin (Lactoferrin) · Thyroglobulin · Alpha-lactalbumin
|
|
Albumins |
Egg white
|
Conalbumin · Ovalbumin · Avidin
|
|
Serum albumin
|
Human serum albumin · Bovine serum albumin · Prealbumin
|
|
Other
|
C-reactive protein · Lactalbumin (Alpha-lactalbumin) · Parvalbumin · Ricin
|
|
|
see also disorders of globin and globulin proteins
B proteins: BY STRUCTURE: membrane, globular (en, ca, an), fibrous
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Synthesis and evaluation of tripeptidic plasmin inhibitors with nitrile as warhead.
- Teno N, Otsubo T, Gohda K, Wanaka K, Sueda T, Ikeda K, Hijikata-Okunomiya A, Tsuda Y.SourceHiroshima International University, Faculty of Pharmaceutical Sciences, 5-1-1, Hirokoshingai, Kure, Hiroshima, 737-0112, Japan.
- Journal of peptide science : an official publication of the European Peptide Society.J Pept Sci.2012 Sep 7. doi: 10.1002/psc.2442. [Epub ahead of print]
- Plasmin is best known as the key molecule in the fibrinolytic system, which is critical for clot lysis and can initiate matrix metalloproteinase (MMP) activation cascade. Along with MMP, plasmin is suggested to be involved in physiological processes that are linked to the risk of carcinoma formation
- PMID 22961872
- Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
- Nishiyama T, Kohno Y, Koishi K.AbstractPURPOSE: We hypothesized that antithrombin is more effective for disseminated intravascular coagulation (DIC) than is gabexate mesilate, which is a protease inhibitor, suggested from the previous studies. Initially, we compared the effects of antithrombin and gabexate mesilate for treating infection-related DIC.
- The American journal of emergency medicine.Am J Emerg Med.2012 Sep;30(7):1219-23. Epub 2011 Dec 26.
- PURPOSE: We hypothesized that antithrombin is more effective for disseminated intravascular coagulation (DIC) than is gabexate mesilate, which is a protease inhibitor, suggested from the previous studies. Initially, we compared the effects of antithrombin and gabexate mesilate for treating infection
- PMID 22204993
Japanese Journal
- A Class of Novel Plasmin Inhibitors
- GOHDA Keigo,TENO Naoki,WANAKA Keiko,TSUDA Yuko
- Peptide science : proceedings of the ... Japanese Peptide Symposium 2010, 259, 2011-03-01
- NAID 10028238100
- Novel Situations of Endothelial Injury in Stroke — Mechanisms of Stroke and Strategy of Drug Development: Novel Mechanism of the Expression and Amplification of Cell Surface–Associated Fibrinolytic Activity Demonstrated by Real-Time Imaging Analysis
- Suzuki Yuko,Urano Tetsumei
- Journal of Pharmacological Sciences 116(1), 19-24, 2011
- … PA inhibitor-1 (PAI-1) facilitated dissociation of tPA-GFP by forming a high molecular weight complex. …
- NAID 130000663523
Related Links
- inhibitor /in·hib·i·tor/ (in-hib´ĭ-tor) 1. any substance that interferes with a chemical reaction, growth, or other biologic activity. 2. a chemical substance that inhibits or checks the action of a tissue organizer or the growth of ...
- plasmin /plas·min/ (plaz´min) an endopeptidase occurring in plasma as plasminogen, which is activated via cleavage by plasminogen activators; it solubilizes ... Structure of an anti-plasmin inhibitor, eckol, isolated from the brown alga ...
★リンクテーブル★
[★]
- 関
- antifibrinolytic agent、antifibrinolytics、plasmin inhibitor
[★]
抗線溶薬
- 関
- antifibrinolytic、antifibrinolytic agent、antiplasmin、plasmin inhibitor
[★]
- 英
- plasmin inhibitor
- 関
- プラスミン阻害因子、抗線溶薬、抗プラスミン薬
[★]
- 関
- antifibrinolytic、antifibrinolytics、antiplasmin、plasmin inhibitor
[★]
- 英
- plasmin inhibitor
- 関
- プラスミン・インヒビター
[★]
プラスミン・α2プラスミンインヒビター複合体
[★]
α2-プラスミンインヒビター欠乏症
[★]
- 関
- abrogate、block、depress、depression、deter、inhibition、interdict、prevent、prevention、repress、repression、restrain、restraint、suppress、suppression
[★]
- 関
- blocker、depressant、suppressant